Human immunodeficiency virus (HIV) infection is a worldwide health problem \[[@ref1]\]. Although the worldwide incidence of HIV infection has decreased, the prevalence of HIV infection has increased with the increased life expectancy among patients receiving antiviral treatment (ART) \[[@ref2]\].

Many studies reported that HIV was mainly transmitted through parenteral exposure, sexual activity, and body secretions, such as saliva and semen \[[@ref1]--[@ref3]\] A high HIV RNA level in blood is the greatest risk factor for the transmission of HIV \[[@ref4]\] Risk of transmission can be reduced through early diagnosis, protection and decreasing HIV RNA levels by early treatment \[[@ref5]\].

HIV-positive individuals get in contact with others in their daily lives. Health providers are in daily contact with patients, their blood and fluids. Some of the patients may be infected, or their fluids may be contaminated with HIV. Otorhinolaryngologists often get in contact with the face and scalp of patients during the physical examination, which gives rise to doubts about HIV transmission through exposure to sweat. Although reference books state that HIV is not transmitted via sweat, to our knowledge, there is no systematic study on which this statement is based. In this study, we aimed to investigate the potential of contact with the sweat of HIV-positive patients to cause HIV infection.

MATERIALS AND METHODS {#sec1-2}
=====================

This study was approved by the local ethics committee. The patients were divided into two groups. Group 1 consisted of 31 treatment-naive HIV RNA-positive patients who were in the acute phase of the infection and Group 2 included 26 subjects with a negative HIV RNA test who had received antiviral treatment. The participants were asked to walk until they sweat. Sweat samples were collected from the face by an otorhinolaryngologist and put in sterile Eppendorf tubes. 0.5 cc sterile saline was added to the tubes and the samples were placed in a deep freeze (-32°C). After the collection of all the samples, the presence of HIV RNA was evaluated using the PCR method.

HIV RNA extraction followed by amplification and detection was performed according to the methodology mentioned elsewhere \[[@ref6]\]. Briefly, RNA was extracted using the ready-to-use RNA extraction kit (QIAampUltraSens, QIAGEN, Hilden, Germany) according to the manufacturer's instructions. A 240 bp region of HIV RNA was reverse transcribed and amplified. Amplification and detection were performed in Rotor-Gene 2000/3000 (Corbett Research, Hamburg-Germany). Amplification protocol was as follows: one cycle of 50°C for 10 min, 45 cycles of 95°C for 8 s, 55°C for 20 s, and 72°C for 20 s.

RESULTS {#sec1-3}
=======

A total of 57 patients were included in this study. The study group consisted of three (5.2%) female and 54 (94.7%) male patients. The mean age of the patients was 34.8±10.9 years (range: 21--71). PCR assay showed no detectable HIV RNA in sweat samples of the two groups ([Table 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). HIV RNA levels in serum and sweat samples are shown in [Table 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}.

###### 

Sweat HIV RNA concentrations and serological parameters in group 1

  Patient no.   Gender   Age   ART     CD4    Serum HIV RNA (IU)   Sweat HIV RNA
  ------------- -------- ----- ------- ------ -------------------- ---------------
  1             M        26    Naive   362    476973               None detected
  2             M        26    Naive   803    329                  None detected
  3             M        59    Naive   8      775,774              None detected
  4             M        26    Naive   1046   114                  None detected
  5             M        45    Naive   481    3290                 None detected
  6             M        26    Naive   675    19200                None detected
  7             F        23    Naive   398    183303               None detected
  8             M        40    Naive   255    626246               None detected
  9             M        27    Naive   262    16410                None detected
  70            M        29    Naive   244    2187265              None detected
  11            M        21    Naive   287    482929               None detected
  12            M        24    Naive   807    1068449              None detected
  13            M        37    Naive   906    102156               None detected
  14            M        32    Naive   410    87748                None detected
  15            M        31    Naive   254    14854                None detected
  16            M        30    Naive   301    322190               None detected
  17            M        33    Naive   382    928394               None detected
  18            M        22    Naive   170    610494               None detected
  19            M        42    Naive   209    583                  None detected
  20            M        44    Naive   372    248,726              None detected
  21            M        36    Naive   312    5169                 None detected
  22            M        34    Naive   230    435523               None detected
  23            M        26    Naive   397    5778788              None detected
  24            M        38    Naive   279    395533               None detected
  25            M        21    Naive   616    436                  None detected
  26            M        28    Naive   237    49902                None detected
  27            M        24    Naive   413    52912                None
  28            M        30    Naive   320    437461               None detected
  29            M        47    Naive   410    214                  None detected
  30            M        29    Naive   646    303,856              None detected
  31            M        45    Naive   226    348,851              None detected

HIV: Human immunodeficiency virus; M: Male; F: Female; ART: Antiretroviral therapy.

###### 

Sweat HIV RNA concentrations, transmission routes, and serological parameters in group 2

  Patient no.   Gender   Age   ART   CD4    Serum HIV RNA (IU)   Sweat HIV RNA
  ------------- -------- ----- ----- ------ -------------------- ---------------
  1             M        44    \+    617    Negative             None detected
  2             M        34    \+    313    Negative             None detected
  3             M        42    \+    346    Negative             None detected
  4             M        49    \+    173    Negative             None detected
  5             M        27    \+    736    Negative             None detected
  6             M        34    \+    966    Negative             None detected
  7             M        39    \+    560    Negative             None detected
  8             F        40    \+    988    Negative             None detected
  9             M        29    \+    999    Negative             None detected
  10            F        33    \+    424    Negative             None detected
  11            M        54    \+    482    Negative             None detected
  12            M        35    \+    691    Negative             None detected
  13            M        28    \+    519    Negative             None detected
  14            M        31    \+    822    Negative             None detected
  15            M        60    \+    594    Negative             None detected
  16            M        51    \+    527    Negative             None detected
  17            M        26    \+    571    Negative             None detected
  18            M        33    \+    680    Negative             None detected
  19            M        22    \+    512    Negative             None detected
  20            M        32    \+    542    Negative             None detected
  21            M        24    \+    791    Negative             None detected
  22            M        25    \+    708    Negative             None detected
  23            M        56    \+    406    Negative             None detected
  24            M        28    \+    1113   Negative             None detected
  25            M        37    \+    350    Negative             None detected
  26            M        71    \+    1223   Negative             None detected

HIV: Human immunodeficiency virus; M: Male; F: Female; ART: Antiretroviral therapy.

DISCUSSION {#sec1-4}
==========

Studies showed that various body fluids, such as genital secretions, semen feces and saliva, may be HIV RNA positive in HIV-positive patients \[[@ref4], [@ref7]--[@ref17]\]. In their study, Kantor et al. reported that HIV RNA was detected in genital secretions in 82 out of 143 HIV-positive patients \[[@ref7]\]. Cotten et al. found HIV RNA in 12 out of 20 feces samples \[[@ref9]\]. In their cross-sectional study, Liuzzi et al. detected HIV1 RNA in 25 semen samples out of 26 \[[@ref10]\]. Balamane et al. reported measurable saliva HIV-1 RNA in 36 of 47 (77%) patients with plasma viremia \[[@ref12]\]. Lourenco et al. \[[@ref13]\] detected HIV RNA in 34 saliva samples out of 57 and suggested that saliva may facilitate HIV entry and possibly other pathogens via the genital mucosa during heterosexual intercourse ([Table 3](#T3){ref-type="table"}). Detection of HIV RNA in samples collected, even from patients receiving the treatment demonstrates that the most efficient way to halt the disease progression is to know the ways of transmission and protection against transmission.

###### 

Studies on the prevalence of HIV RNA in different body fluids or secretions of HIV positive patients

  Study                               HIV positive body fluid/secretion   Body fluid/secretion   Positive HIV RNA in body fluid/secretion %
  ----------------------------------- ----------------------------------- ---------------------- --------------------------------------------
  Kantor et al. 2014 \[[@ref7]\]      143                                 Genital secretion      57
  Cotten et al. 2014 \[[@ref9]\]      20                                  Feces                  12
  Liuzzi et al. 1996 \[[@ref10]\]     26                                  Semen                  25
  Balamane et al. 2010 \[[@ref12]\]   47                                  Saliva                 36
  Lourenço et al. 2014 \[[@ref13]\]   57                                  Saliva                 59
  Mohlala et al. 2005 \[[@ref11]\]    23                                  Amniotic fluid         0
  Mohlala et al. 2005 \[[@ref11]\]    23                                  Fetal cord blood       0
  Hanege et al. 2015 \[[@ref6]\]      78                                  Cerumen                0
  Current study                       57                                  Sweat                  0

HIV: Human immunodeficiency virus.

In addition to these studies showing the ways of transmission, there have been various studies reporting no HIV RNA in some body fluids. In a previous study, HIV RNA was not detected by PCR in-ear cerumen of patients with a positive test for serum HIV RNA \[[@ref6]\]. Likewise, in a study, including 23 patients infected with HIV, Mohlala et al. \[[@ref11]\] reported that no HIV RNA was found in amniotic fluids and umbilical cord blood of 23 HIV-infected pregnant women who received single-dose nevirapine or short-term zidovudine treatment before elective cesarean section ([Table 3](#T3){ref-type="table"}).

Although some statements are suggesting that HIV is not transmitted through sweat, in the literature, there are only a limited number of studies that we conducted on patients with a positive test for serum HIV RNA supporting those statements. Wormser et al. could not demonstrate HIV-RNA in eccrine sweat samples of 50 HIV-infected patients \[[@ref18]\]. Reliable information and comment on this matter require more scientific research on patient samples. Thus, in this study, to base the subject upon a scientific foundation, we evaluated 31 treatment-naive HIV RNA-positive patients who were in the acute phase of the infection and 26 subjects with a negative HIV RNA test who had received ART. All sweat samples analyzed using PCR were found to be negative for HIV RNA. This finding was a scientific result supporting the statements having no scientific basis in the literature.

Conclusion {#sec2-1}
----------

The findings obtained in this study suggest that sweat from an HIV-infected individual that is not contaminated with blood or other body fluids has no potential for transmitting HIV infection even if serum HIV RNA level of the patient is considerably high. This result certainly does not ignore the necessity of precautions to prevent transmission of HIV during medical interventions or other approaches. General infection prevention should be precisely implemented.
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